Apimeds Pharmaceuticals US (APUS US)

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company. The Company specializes in developing an intradermally administered bee venom-based toxin which exhibits diverse therapeutic effects. Apimeds Pharmaceuticals US operates in the United States.